However, as tumor genetic testing becomes more accessible and larger CM datasets become available, our knowledge of poor prognosis-related genetic changes has also been advancing (i.e., mutations affecting NRAS, TERT, or uveal melanoma-related genes/hotspots and recurrent deletions affecting 10q24-26) although awaiting validation in additional/independent studies. This evidence concerns the gene NRAS and neoplasm.